Cameron DA - Search Results

1

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.

Taylor KJ, Sims AH, Liang L, Faratian D, Muir M, Walker G, Kuske B, Dixon JM, Cameron DA, Harrison DJ, Langdon SP. Taylor KJ, et al. Among authors: cameron da. Breast Cancer Res. 2010;12(3):R39. doi: 10.1186/bcr2593. Epub 2010 Jun 22. Breast Cancer Res. 2010. PMID: 20569502 Free PMC article.

2

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer.

Keen JC, Dixon JM, Miller EP, Cameron DA, Chetty U, Hanby A, Bellamy C, Miller WR. Keen JC, et al. Among authors: cameron da. Breast Cancer Res Treat. 1997 Jun;44(2):123-33. doi: 10.1023/a:1005796915388. Breast Cancer Res Treat. 1997. PMID: 9232271

3

Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression.

Cameron DA, Ritchie AA, Langdon S, Anderson TJ, Miller WR. Cameron DA, et al. Breast Cancer Res Treat. 1997 Sep;45(2):99-107. doi: 10.1023/a:1005850827825. Breast Cancer Res Treat. 1997. PMID: 9342435

4

Lessons from the use of aromatase inhibitors in the neoadjuvant setting.

Dixon JM, Love CD, Renshaw L, Bellamy C, Cameron DA, Miller WR, Leonard RC. Dixon JM, et al. Among authors: cameron da. Endocr Relat Cancer. 1999 Jun;6(2):227-30. doi: 10.1677/erc.0.0060227. Endocr Relat Cancer. 1999. PMID: 10731113 Review.

5

Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes.

Cameron DA, Keen JC, Dixon JM, Bellamy C, Hanby A, Anderson TJ, Miller WR. Cameron DA, et al. Eur J Cancer. 2000 May;36(7):845-51. doi: 10.1016/s0959-8049(00)00013-7. Eur J Cancer. 2000. PMID: 10785588

6

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.

Cameron DA, Gregory WM, Bowman A, Anderson ED, Levack P, Forouhi P, Leonard RC. Cameron DA, et al. Br J Cancer. 2000 Jul;83(1):98-103. doi: 10.1054/bjoc.2000.1216. Br J Cancer. 2000. PMID: 10883676 Free PMC article.

7

The relative importance of proliferation and cell death in breast cancer growth and response to tamoxifen.

Cameron DA, Ritchie AA, Miller WR. Cameron DA, et al. Eur J Cancer. 2001 Aug;37(12):1545-53. doi: 10.1016/s0959-8049(01)00166-6. Eur J Cancer. 2001. PMID: 11506964

Thus, using a model system based on oestrogen receptor (ER)-positive ZR-75-1 breast cancer xenografts, both increased apoptosis and reduced proliferation have been previously shown to occur within 7 days of tamoxifen therapy (Cameron DA, Ritchie AA, Langdon S, Ander …

Thus, using a model system based on oestrogen receptor (ER)-positive ZR-75-1 breast cancer xenografts, both increased apoptosis and reduced …

8

Letrozole as primary medical therapy for locally advanced and large operable breast cancer.

Dixon JM, Love CD, Bellamy CO, Cameron DA, Leonard RC, Smith H, Miller WR. Dixon JM, et al. Among authors: cameron da. Breast Cancer Res Treat. 2001 Apr;66(3):191-9. doi: 10.1023/a:1010669403283. Breast Cancer Res Treat. 2001. PMID: 11510690 Clinical Trial.

9

Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy.

Miller WR, Dixon JM, Cameron DA, Anderson TJ. Miller WR, et al. Among authors: cameron da. J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):103-7. doi: 10.1016/s0960-0760(01)00149-2. J Steroid Biochem Mol Biol. 2001. PMID: 11850213

10

Should all adjuvant breast cancer patients receive a bisphosphonate?

Cameron DA. Cameron DA. Breast Cancer Res. 2003;5(6):296-9. doi: 10.1186/bcr648. Epub 2003 Oct 1. Breast Cancer Res. 2003. PMID: 14580244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters